| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |